Background Elimination of schistosomiasis as a public health problem and interruption of transmission in selected areas are targets set by WHO for 2025. Our aim was to assess biannual mass drug administration (MDA) applied alone or with complementary snail control or behaviour change interventions for the reduction of Schistosoma haematobium prevalence and infection intensity in children from Zanzibar and to compare the effect between the clusters.
Introduction
Schistosomiasis is a parasitic disease caused by infection with blood flukes of the genus Schistosoma. 1 An estimated 800 million people are at risk of infection and more than 200 million people are infected. 2 In 2016, the global burden of schistosomiasis was 1·86 million disability-adjusted life years. 3 Over the past 15 years, substantial progress has been made in the control of schistosomiasis. There has been a shift from morbidity control towards elimination in selected areas and new targets have been issued by WHO: elimination of schistosomiasis as a public health problem (prevalence of heavy intensity infections below 1% in all sentinel sites) and interruption of transmission (reduction of incidence of infection to zero) in selected areas by 2025. 1, 4 The Zanzibar archipelago, offshore from Tanzania, is one of the first settings in sub-Saharan Africa targeted for elimination of urogenital schistosomiasis as a public health problem and interruption of transmission.
The cornerstone of schistosomiasis control is mass drug administration (MDA) with praziquantel, but moving towards elimination will require complementary measures. [4] [5] [6] Suggested measures to reach interruption of transmission in selected areas where transmission is low and highly focal include intensified treatment (ie, treatment intervals shorter than 12 months and targeting not only school-aged but also preschool-aged children and adults, including women of reproductive age) plus intermediate host snail control, improvements in access to clean water, sanitation, and hygiene (WASH) to reduce and ideally impede the contamination of freshwater bodies, and interventions to assist people in changing their behaviour to prevent transmission and infection. 4, [7] [8] [9] [10] Our objectives were to assess biannual MDA applied alone or with complementary snail control or behaviour change interventions for the reduction of Schistosoma haematobium prevalence and infection intensity in children from Zanzibar and to compare the effect between the clusters.
Methods

Study design and participants
The Zanzibar archipelago consists of two main islands: Pemba and Unguja. Each island is divided into districts, which are subdivided into small administrative units called shehias. In 2012, the national census recorded 121 shehias in Pemba and 210 shehias in Unguja. The total population is estimated at 1·3 million. Urogenital schistosomiasis caused by infection with S haematobium has been highly prevalent in the past century, with prevalences exceeding 50% in some places, but was reduced to an overall prevalence below 10% in 2012. [11] [12] [13] [14] It is hence important to note that our trial was done in a setting that had been exposed to MDA with praziquantel for several years and that our baseline population in 2012 was mostly not naive to treatment. 13 The study was a 5-year cluster-randomised open-label trial with three intervention arms. The study design has been published elsewhere. 15 We included children aged 9-12 years. From 2012 to 2017, annually, a single urine sample was collected from approximately 100 children aged 9-12 years in the main public primary school of each of the 90 study shehias. A shehia was defined as the cluster and intervention unit. The trial was done in 90 shehias on Pemba and Unguja, from Nov 1, 2011, through to Dec 31, 2017 , and recruitment took place from Nov 2, 2011 , until May 17, 2017 . Interventions in all arms started within one year after the baseline survey in 2012 and were intensified until the endline survey in early 2017. The first community-wide treatment MDA round was conducted on April 28, 2012 
Added value of this study
We did a 5-year cluster-randomised trial to assess the effect of different interventions for elimination of urogenital schistosomiasis as a public health problem and interruption of transmission. Biannual MDA with praziquantel was offered to all age groups with the exception of children below the age of 3 years across the Zanzibar islands. New behavioural interventions were developed in a human centred design approach and applied in randomised communities. The capacity for snail control was established. In randomised communities, water bodies containing intermediate host snails were targeted by focal mollusciciding. Our trial showed that biannual MDA applied alone or in combination with snail control or behaviour change activities can substantially reduce the overall Schistosoma haematobium prevalence and infection intensity. Urogenital schistosomiasis was eliminated as a public health problem from Zanzibar in more than 90% of the shehias included in the study, but transmission is not yet interrupted and reinfection occurs. Although randomised additional interventions in our study did not significantly boost the effect of MDA, they might enhance interruption of transmission when tailored to focal endemicity and applied for a longer period.
Implications of all the available evidence
Schistosomiasis is a focal disease. In settings where elimination as a public health problem and interruption of transmission is the goal, intervention strategies need to be tailored to the local micro-epidemiology and culture. It is now necessary to build on the experience gained in this trial and other studies, to focus on reducing prevalence and intensity in remaining hotspot areas, and to introduce new methods of rigorous surveillance, followed by specific public health response so that the important gains can be maintained and advanced.
Ethikkommission beider Basel (EKBB) in Basel, Switzerland (reference no. 236/11) and the Institutional Review Board of the University of Georgia in Athens, GA, USA (project no. 2012-10138-0). Written informed consent was obtained from the parents or guardians of participating children.
Randomisation and masking
Stratified by island, shehias were randomly allocated to one of three intervention arms (ratio 1:1:1), as described elsewhere. 15 In brief, 15 shehias on each island received biannual MDA with praziquantel administered by the Neglected Tropical Diseases (NTD) Programme of the Zanzibar Ministry of Health across the archipelago (arm 1); 15 shehias received snail control in addition to biannual MDA (arm 2); and 15 shehias received behaviour change interventions in addition to biannual MDA (arm 3). Owing to the nature of the intervention, neither participants nor field or laboratory personnel were blinded to the intervention arms.
Outcomes
The primary outcome was S haematobium infection prevalence and intensity in 9-12-year-old children in Zanzibar in 2017 after 5 years of follow-up at individual and cluster level. The primary outcome was reworded after registration of the study to meet the appropriate definition of a variable 16 and to point out the main trial population. The change in the primary outcome was based on the recommendation of trialists who supported the preparation of the statistical analysis plan (appendix) and decided upon by the trial leadership and the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) secretariat. The decision to reword the primary outcome was done before the statistician had access to the data for analysis. Secondary outcomes including the S haematobium prevalence and intensity in first-year students and adults are presented elsewhere. 17 No outcomes were excluded from the analyses.
Procedures
The baseline survey was done in the primary schools of the 90 study shehias in early 2012, with annual followup surveys done in early 2013, 2014, 2015, 2016, and 2017 . The purpose and procedures of the study were explained to eligible children. Once we received the informed consent form signed by the parents or guardians, the participants were provided with a plastic container and instructions for urine collection between 09:00 h and 14:00 h the following day. A single urine sample from each participant was transferred to the laboratory of the NTD Programme in Unguja or to the Public Health Laboratory-Ivo de Carneri in Pemba. Each urine sample of sufficient quantity was visually examined for macrohaematuria, for microhaematuria by means of reagent strips (Haemastix; Siemens Healthcare Diagnostics GmbH, Camberley, Surrey, UK), and for S haematobium eggs, by means of the filtration method. 17 10% of all urine samples were reread by a senior laboratory technician for quality control. In the months following the survey, MDA was done in schools and communities and praziquantel (40 mg/kg) was offered to the whole eligible population. Treatment coverage data were collected as described elsewhere in detail. 18 Praziquantel was administered biannually across both islands, in all shehias located in Pemba and Unguja, with the exception of the South district and the Urban A and B subdistricts in Unguja. 17 In community-wide treatment (CWT), implemented twice per year from April, 2012 onward, praziquantel was distributed by trained community drug distributors (CDDs) to the whole eligible population, excluding children younger than 3 years, children treated during school-based treatment (SBT), severely sick people, and pregnant women. 18 In additional SBT, implemented for the first time in MDA round 4, praziquantel was administered to schoolchildren by teachers by means of a dose pole and the intake of drugs was directly observed. Data on treatment coverage of CWT was collected from the records of CDDs and of SBT from teachers, by staff of the Zanzibar Ministry of Health. Our project staff collected additional data on treatment coverage and compliance during the annual cross-sectional surveys in schools and communities. 16, 18 For snail control activities, human water contact sites (HWCSs) were identified in the 30 study shehias before and over the course of the trial with the help of local knowledge and information. Trained teams did surveys for intermediate host snails (Bulinus spp) at each HWCS multiple times per year outside of the heavy rainy season. For this purpose, approximately 15 m of the shoreline were measured and searched for snails of all species by two collectors for 15 min, using their hands and snail scoops. 19 The molluscicide niclosamide (Bayluscide; donated by Bayer SAS, Monheim, Germany) was sprayed at HWCSs only if Bulinus spp were present. 17 Niclosamide wettable powder was mixed with pond water (according to manufacturer's instructions) and applied to the shoreline around the HWCS with Hudson backpack sprayers or a petrol power spraying machine, depending on the environment. The HWCS's location, type, water chemistry, presence of snails, and niclosamide spraying were recorded at each survey.
Community co-designed behaviour change interventions were developed and implemented in the 30 study shehias in a staggered approach by trained teams. 20 Classroombased and school-wide intervention components were done by trained primary school teachers and religious school teachers using culturally tailored, interactive tools, materials, and engagement methods developed within the programme (eg, flipcharts, blood fluke pictures, snail boards, and self-drawing of schistosome life-cycles) to teach children about schistosomiasis transmission and prevention. 20, 21 Teachers and children did regularly, schoolwide, Kichocho Day Events incorporating dramas, poems, and games that focused on schistosomiasis transmission, prevention, and treatment. Parents and other community members were encouraged to participate in Kichocho Day Events and interactive health education activities. Community-based interventions included community meetings, evening educational films, and the construction of one male and one female urinal per shehia near a freshwater body with known schistosomiasis transmission.
In the second half of the project, community co-designed washing platforms were constructed in close proximity to a safe water source in behavioural shehias with the highest disease prevalence. Data on school census and children exposed to the interventions as well as community intervention components were collected over the course of the implementation process.
Statistical analysis
The sample size calculation, eligibility criteria, and randomisation procedures of clusters and study participants are described in the published study protocol. 15 In brief, to reach a desired power of 80%, the sample size of clusters (ie, shehias) exceeded the total number of schistosomiasis-endemic shehias in Unguja and Pemba and the sample size of participants was logistically not feasible. Hence, the choice of 15 shehias per intervention arm per island, and the number of people to be tested was a compromise between what was considered optimal and what was practically achievable. Participants were considered S haematobium-positive if the urine filtration method revealed at least one S haematobium egg per 10 mL urine, or, in the absence of a urine filtration result, if microhaematuria was detected with reagent strips. Infection intensities were classified into light (1-49 eggs per 10 mL urine) and heavy (≥50 eggs per 10 mL urine) according to WHO thresholds. 22 Egg counts were truncated at 1000 eggs per 10 mL urine.
The absolute and relative difference (% change) in the S haematobium prevalence at baseline in 2012 and endline in 2017 were calculated. Arithmetic mean (AM) egg counts, including zeros, were calculated at baseline and endline as a proxy for transmission force at shehia level; AM egg counts, excluding zeros, were calculated at baseline and endline as a proxy for transmission force at individual level. The AM egg reduction rate from 2012 to 2017 was calculated by means of the following formula: 1−AM egg counts in 2017/AM egg counts in 2012. Generalised estimating equation models with binary logit functions and negative binomial distributed outcomes with log link functions, and independent correlation structure were applied to compare trial arms. All models used robust variance estimators to account for correlation within clusters (ie, the school). Biannual MDA alone was the designated reference group. For unadjusted estimates, only infection status (as outcome) and treatment arm were included in the model. In the adjusted analysis, sex and age were included in the model as explanatory variables. In addition, the observations in the adjusted analysis were weighted by the inverse cluster size (probability weights), which ensures that each cluster contributes equally to the generalised estimating equation, regardless of its size. Data are number (%), or n/N (%), unless otherwise stated. MDA=mass drug administration. SD=standard deviation. *One school in the biannual MDA plus snail control group and one school in the biannual MDA plus behaviour change group were not surveyed at baseline. †S haematobium-positive is defined as urine filtration egg-positive or, in the absence of a urine filtration result, as haematuria-positive (trace, +, ++, and +++). ‡The intensity of S haematobium infection was categorised as negative (0 eggs per 10 mL of urine), light (1-49 eggs per 10 mL of urine), or heavy (≥50 eggs per 10 mL of urine). Intra-class correlation was established by means of mixed models consistent with the generalised estimating equation, setup in the primary analysis. Given the relatively high number of clusters, balance in baseline characteristics was a reasonable assumption. Since we detected some discrepancy in baseline prevalence among the three trial arms, we complemented the results with an exploratory analysis using different types of adjustment for baseline prevalence.
Treatment coverage was calculated as described elsewhere in detail. 18 Descriptive statistics were done by means of Stata IC 14 (StataCorp; College Station, TX, USA), the primary analyses and interaction models by SAS version 9.4 and the inverse probability weight model was fitted by the ipw package of R version 3.4.3 by two of the authors (SK and JH). 
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OR=odds ratio. CR=count ratios. *Sex and age are also included in the model, along with weighting for number of children who provided data, because not all schools were able to sample 100 children aged 9-12-years. †Baseline year (2012) is the reference. ‡Clusters are inversely weighted by their baseline prevalence as continuous variables. MDA=mass drug administration. *Schistosoma haematobium-positive is defined as urine filtration egg-positive or, in the absence of a urine filtration result, as haematuria-positive (trace, +, ++, and +++). †The intensity of S haematobium infection was categorised as negative (0 eggs per 10 ml of urine), light (1-49 eggs per 10 mL of urine), or heavy (≥50 eggs per 10 mL of urine). The study is registered with the ISRCTN, number 48837681.
Role of the funding source
The SCORE secretariat was involved in the trial design. The funder of the study had no role in data collection, data analysis, data interpretation, patient recruitment, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
The study flow and baseline characteristics are indicated in figure 1 . The timeline and frequency of all interventions and surveys are illustrated in figure 2. 291 shehias were assessed for eligibility and 45 shehias on each island were randomly allocated to one of three study arms. At baseline, 2853 schoolchildren aged 9-12 years were surveyed from 30 schools in arm 1, 2688 children from 29 schools in arm 2, and 2613 children from 29 schools in arm 3. In arms 2 and 3, a non-randomised school was surveyed, and hence, excluded from further analyses. At the endline survey, 3184 children aged 9-12 years were surveyed from 30 schools in arm 1, 3217 children from 30 schools in arm 2, and 3080 children from 29 schools in arm 3. In arm 3, one school was lost to follow-up since it was transformed into a secondary school. Table 1 indicates between-group differences of the S haematobium prevalence in arm 1 (4•2%) and in arm 2 (7•8%), or in arm 3 (6•4%), of the AM egg counts per 10 mL urine in arm 1 (2•8 eggs) and in arm 2 (5•7 eggs), or in arm 3 (5•3 eggs), and of the percentage of heavy infection intensities in arm 1 (0•9%) and in arm 2 (1•8%), or in arm 3 (2•0%). The trial arms were balanced with respect to age and sex of the participants. The results of exploratory analysis by means of different models to adjust for imbalance in S haematobium prevalence at baseline suggested a greater effect of snail control compared with MDA alone with consistent OR estimates ranging from 0•63 to 0•65. However, 95% CIs were broad and the difference not significant (table 3) . Likewise, behaviour change intervention showed slight improvements but the point estimates were less consistent and closer to unity (OR: 0•82-1•06).
In MDA rounds 1, 2, 3, and 5 on both islands and in Unguja also in round 6, children were targeted by CWT. Table 4 shows that the coverage in these rounds, stratified by study arm, ranged from 63•8% to 86•6% as determined by NTD Programme staff. In rounds 4, 7, 8, 9, and 10 on both islands and in Pemba also in round 6, children received praziquantel by SBT. The coverage of SBT ranged from 72•2% to 90•4% when assessed by NTD Programme staff and from 69•8% to 98•1% in the trial coverage surveys.
In the 15 shehias in Pemba, snail control was applied in a large and constant number of HWCSs identified and visited from 2012 until 2016 ( NA=not assessed. KDE=Kichocho Day Event. *Two washing platforms had no water and one needed minor repair. †One public primary school closed before the end of the study and changed the school type to secondary school only. ‡The six platforms were not used because the safe water source nearby was no longer functioning (wells dried; tap water has been cut). (table 6 ). The washing platforms installed in 2014 and 2015 were used frequently by all sexes and agegroups. The urinals were not frequently used, probably because of lack of maintenance by the community, and rapidly fell into disrepair.
Discussion
Over the past decades, examples from several countries and areas have shown that elimination of schistosomiasis is feasible. Countries having achieved interruption of transmission reported economic improvements, the integrated use of MDA, intermediate host snail control, or improved access to WASH. 5 We assessed the effect of snail control and behaviour change interventions on top of biannual praziquantel MDA for the reduction of S haematobium prevalence and infection intensity among 9-12-year-old children from Zanzibar, one of the first settings in sub-Saharan Africa where interruption of transmission seems to be a feasible goal, in a 5-year repeated cross-sectional cluster-randomised open-label trial. Three key messages emerged from our results. First, biannual MDA alone or in combination with snail control or behaviour change interventions substantially reduced the overall S haematobium prevalence and infection intensities and eliminated schistosomiasis as a public health problem from most areas in Zanzibar. Second, biannual MDA was not sufficient to interrupt transmission in 5 years, even if accompanied by additional measures at small scale. Third, there was considerable spatial and temporal heterogeneity of infections.
Of note, although snail control or behaviour change activities did not significantly boost the effect of biannual MDA over the time of the project and at the scale used, they might contribute to further reducing prevalence and enhance interruption of transmission when tailored to focal endemicity, implemented with high coverage and good access to WASH, and applied for a longer period.
The following main challenges should be considered. Although MDA coverage was high in schools, it was low in the community. Non-covered or non-complying individuals might have served as a reservoir of infection contributing to continued transmission. Cure rate (73•6%) and egg reduction rate (94•7%) of praziquantel against S haematobium are not perfect. 23 People are mobile and might have acquired infection in a neighbouring shehia without snail control interventions. Focal application and sporadic coverage of HWCSs with niclosamide to minimise environmental effect does not prevent snails from repopulating the treated freshwater bodies quickly, maintaining the possibility of parasite transmission. Behaviour change needs time to initiate and adopt, and requires access to child-friendly WASH.
Although not as obvious as persistent hotspots in other studies, 24, 25 some pockets with high risk of transmission remained on both islands. These were characterised by a large number of HWCSs containing intermediate host snails and being located in close proximity to schools or settlements. 19, 26 In such high-risk ecological settings, MDA alone might suppress transmission only partially. 27 Continuing towards the end game of elimination, these areas will need targeted integrated interventions applied with high coverage. To prevent a re-emergence of infection in low-risk and zero-prevalence areas, new tools and strategies tailored to the changing endemic landscape that detect cases and transmission spots with a high sensitivity and trigger interventions that are accepted by a mostly non-infected community are needed. Moving from schistosomiasis control towards elimination as a public health problem and interruption of transmission will require an adaptive strategy, progressing from widespread MDA towards selective interventions and surveillanceresponse mechanisms. 6, 9, 28, 29 Translational research to assess the feasibility of combined interventions in hotspot and adequate surveillance-response approaches in lowendemicity areas might provide evidence on how to sustain and further advance the gains made to date, with the ultimate goal of reaching interruption of transmission.
Limitations of our study are that our intervention units were randomly allocated before and not after assessment of the baseline prevalence. Given the low prevalence at the endline survey, our trial was not powered to detect small but biologically important effects as significant differences. Owing to the very low number of positive individuals in this elimination setting, a sufficiently large cluster and participant number was operationally not feasible. 17 Urine filtration and reagent strip methods are not highly sensitive, particularly if infection intensities are very light. 30 Use of more rigorous diagnostic approaches and tests with higher sensitivity would probably have resulted in a higher S haematobium prevalence and a clearer picture of the real effect of interventions. 31 Moreover, all of the interventions were implemented and intensified over time and readily available only in 2015. Since we did not assess the abundance and infection of intermediate host snails in shehias outside the snail control arm, it was not possible to compare the number of infected snails across the different arms. As streams and water bodies might run and extend through different shehias, a future control strategy for the whole island should consider treating HWCSs along the whole course of the water body irrespective of the shehia boundaries. Self-reported behaviour change was qualitatively assessed in children by visiting schools in arms 1, 2, and 3 through a mixed methods study at the end of the project (manuscript in preparation). Children targeted by behavioural interventions reported now taking praziquantel during MDA, and having stopped bathing and washing in the river more frequently than children from the other arms (manuscript in preparation). Hence, although no significant difference of added snail control or behavioural change interventions compared with MDA alone was detected in the extremely low S haematobium prevalences in our endline survey, the effect of these interventions might be reflected elsewhere.
Urogenital schistosomiasis was eliminated as a public health problem from Zanzibar in more than 90% of the shehias included in the study, but transmission is not yet interrupted and reinfection occurs. It is now necessary to build on the experience gained in the trial, to focus on reducing prevalence in the remaining hotspot areas by biannual MDA plus additional measures implemented with high coverage, and at the scale needed, and to introduce new surveillanceresponse approaches so that the important gains can be maintained and advanced.
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